Twist Bioscience Corporation

NASDAQ:TWST

Medical - Diagnostics & Research

Healthcare
$116.35 +2.59%

+$2.15 today

Market cap
$7.66B
Beta
2.21
P/E (TTM)
-64.5
EPS (TTM)
-$1.32
52W Low $23.30High $88.46

Volume 2.23M

Average 1.53M

TWST Minority Interest

The portion of consolidated subsidiaries' equity owned by outside shareholders.

Twist Bioscience CorporationNASDAQ: TWST

Minority Interest · Q4 FY2026 · quarter ended Sep 2026

Minority interest remains negative

Q4 FY2026 minority interest was $0, compared with $0 a year earlier.

Context

  • Minority interest amounted to 0.0% of total assets at the end of Q4 FY2026, unchanged from a year earlier.
  • Minority interest increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearSep 2026
$0— YoY
Year agoSep 2025
$0— since
Minority Interest past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Minority Interest history

USD · from the balance sheet

Latest · FY2026
0 USD
Year-over-year change
—

Minority Interest vs competitors

How TWST compares with its peers on the latest reported figures

  • TWST's Sep 2026 minority interest of $0 is the highest of the 2 companies compared; the peer median is $0.
  • Minority interest amounts to 0.0% of total assets for TWST, versus a peer median of 0.0%.
TWST Competitors Peer median
Minority Interest for TWST and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TWSTTwist Bioscience CorporationSep 2026$0 ——0.0%
RGENRepligen CorporationJun 2026$0 ——0.0%
Peer median (excluding TWST) $0——0.0%

Competitors are the stored peer set for TWST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Cash & Equivalents378.69M286.47M226.32M183.05M533.99M
Short-term Investments126.28M49.94M50.08M49.39M47.92M
Net Receivables40.29M44.06M34.9M57.32M70.19M
Inventory39.31M32.06M24.08M28.31M46.41M
Other Current Assets011.72M11.4M14.9M38.71M
Total Current Assets596.48M424.26M346.78M332.97M737.22M
Property, Plant & Equipment (Net)214.39M203.36M161.35M151.66M191.6M
Goodwill85.81M85.81M85.81M82.2M82.2M
Intangible Assets59.74M54.48M14.48M13.43M34.16M
Long-term Investments02.81M1.53M54.34M68.09M
Tax Assets00000
Other Non-current Assets4.96M5.68M4.38M7.28M8.54M
Total Non-current Assets364.9M352.15M267.55M308.9M384.58M
Total Assets961.38M776.4M614.32M641.86M1.12B
Account Payables20.09M14.05M1.63M11.09M24.85M
Short-term Debt00013.82M0
Tax Payables3.66M4.37M2.73M00
Deferred Revenue3.48M3M2.13M6.88M0
Other Current Liabilities39.62M26.25M34.61M23.78M54.19M
Total Current Liabilities90.66M73.32M71.01M91.41M125.81M
Long-term Debt00061.75M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities60K475K407K(46M)21.45M
Total Non-current Liabilities81.33M79.65M70.63M77.5M107.98M
Total Liabilities171.99M152.97M141.63M168.9M233.79M
Common Stock00001K
Retained Earnings(828.42M)(1.03B)(1.24B)(1.32B)(1.45B)
Accumulated OCI(1.84M)(756K)(522K)(627K)(680K)
Other Stockholders Equity00002.34B
Minority Interest00000
Total Equity789.39M623.43M472.69M472.96M888.02M
Total Debt94.91M94.07M85.03M137.32M94.99M
Net Debt(283.78M)(192.4M)(141.29M)(45.73M)(439.01M)

Twist Bioscience Corporation

NASDAQ:TWST

Intrinsic Alpha fair value

Locked

Current Price

$116.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.